Comparison of efficacy and safety of erenumab between over and under 65-year-old refractory migraine patients: a pivotal study
Ilaria Cetta, Roberta Messina, Laura Zanandrea, Bruno Colombo, Massimo Filippi
Topics & Concepts
MedicineMigraineAdverse effectAuraInternal medicineChronic MigraineHeadachesNeurologyTopiramatePillEpilepsyPediatricsSurgeryPharmacologyPsychiatryMigraine and Headache StudiesCardiovascular Syncope and Autonomic DisordersTrigeminal Neuralgia and Treatments